Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELE | P16581 | 19/20 | 0.71 |
| ▸ | SELL | P14151 | 1/20 | 0.38 |
| ▸ | SELP | P16109 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12894557 | 0.96 | SELE (0.66) | SELESELLSELP | |
| SCHEMBL13272239 | 0.90 | SELE (0.88) | SELESELP | |
| SCHEMBL17903034 | 0.90 | SELE (0.88) | SELESELP | |
| SCHEMBL12085698 | 0.90 | SELE (0.88) | SELESELP | |
| SCHEMBL18211304 | 0.90 | SELE (0.88) | SELESELP | |
| SCHEMBL12881602 | 0.88 | SELE (0.69) | SELESELP | |
| SCHEMBL12903105 | 0.87 | SELE (0.81) | SELESELLSELP | |
| SCHEMBL12903109 | 0.82 | SELE (0.73) | SELE | |
| SCHEMBL12903231 | 0.82 | SELE (0.73) | SELE | |
| SCHEMBL12903106 | 0.81 | SELE (0.74) | SELESELP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9045523-B2 | Compounds | PHAROS PHARMACEUTICALS INC. (US) | 2015-06-02 | — | — | US | disclosed |
| EP-2144920-B1 | Sulphated amino sugars with anti-inflammatory properties | DIOSAMINE DEV CORP (US) | 2014-08-06 | — | — | EP | disclosed |
| EP-2586786-A1 | Sulphated amino sugars with anti-inflammatory properties | Diosamine Development Corporation (US) | 2013-05-01 | — | — | EP | disclosed |
| WO-2008059003-A1 | NOVEL COMPOUNDS | DIOSAMINE DEVELOPMENT CORPORATION (US) | 2008-05-22 | — | — | WO | disclosed |